Transplantation of bioengineered dermal derived matrix-scaffold in combination with hyperbaric oxygen therapy improves wound healing in diabetic rats
Tissue and Cell · 2024-08 · 89 · 102462
DOI: 10.1016/j.tice.2024.102462 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tissue and Cell, 2024-08. Verfasst von Ali Reza Khalatbary und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cellular and Molecular Research Center, Mazandaran University of Medical Sciences, Sari, Iran. Hauptthemen laut MEDLINE: Hyperbaric Oxygenation, Wound Healing, Diabetes Mellitus, Experimental, Tissue Scaffolds. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Mazandaran University of Medical Sciences.
Themen: Wundversorgung
Abstract (Originalsprache)
Successful treatment of diabetic wounds requires multifactorial approaches. Herein we investigated the effects of a bioengineered three-dimensional dermal derived matrix-scaffold (DMS) in combination with hyperbaric oxygen (HBO) in repairing of wound model in diabetic rats. Thirty days after induction of diabetes, a circular wound was created and treatments were performed for 21 days. Animals were randomly allocated into the untreated group, DMS group, HBO group, and DMS+HBO group. On days 7, 14, and 21, tissue samples were obtained for stereological, molecular, and tensiometrical assessments. Our results showed that the wound closure rate, volume of new dermis and epidermis, numerical density fibroblasts and blood vessels, collagen density, and biomechanical characterize were significantly higher in the treatment groups than in the untreated group, and these changes were more obvious in the DMS+HBO ones. Moreover, the expression of TGF-β, bFGF, miRNA-21, miRNA-146a, and VEGF genes were meaningfully upregulated in treatment groups compared to the untreated group and were greater in the DMS+HBO group. This is while expression of TNF-α and IL-1β, as well as the numerical density of neutrophil and macrophage decreased more considerably in the DMS+HBO group than in the other groups. Overall, using both DMS engraftment and HBO treatment has more effects on diabetic wound healing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cellular and Molecular Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
- Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
- Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.
- Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Clinical, Amol Campus of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
- Student Research Committee, Sabzevar University of Medical Science, Sabzevar, Iran.
Förderung
- Mazandaran University of Medical Sciences
Zitieren
APA
Khalatbary, A. R., Sarabandi, S., Ahmadi, F., Kasmaie, F. M., Sadeghi, N., Soleimani, S., Disfani, R. A., Raoofi, A., & Nasiry, D. (2024). Transplantation of bioengineered dermal derived matrix-scaffold in combination with hyperbaric oxygen therapy improves wound healing in diabetic rats. Tissue and Cell, 89, 102462. https://doi.org/10.1016/j.tice.2024.102462
Vancouver
Khalatbary AR, Sarabandi S, Ahmadi F, Kasmaie FM, Sadeghi N, Soleimani S, et al. Transplantation of bioengineered dermal derived matrix-scaffold in combination with hyperbaric oxygen therapy improves wound healing in diabetic rats. Tissue and Cell. 2024;89:102462. doi:10.1016/j.tice.2024.102462
BibTeX
@article{Khalatbary2024,
author = {Khalatbary, Ali Reza and Sarabandi, Sahel and Ahmadi, Fahimeh and Kasmaie, Farshad Moharrami and Sadeghi, Niloofar and Soleimani, Saman and Disfani, Reza Ataee and Raoofi, Amir and Nasiry, Davood},
title = {Transplantation of bioengineered dermal derived matrix-scaffold in combination with hyperbaric oxygen therapy improves wound healing in diabetic rats},
journal = {Tissue and Cell},
year = {2024},
volume = {89},
pages = {102462},
doi = {10.1016/j.tice.2024.102462}
}
EUVIMED